INS and diabetes mellitus: Among these barriers, fear of death, dependence on others, the difficulty of carrying insulin while traveling, follow-up challenges, the difficulty of dosing accuracy, the difficulty of keeping insulin, inconveniences in daily life, considering insulin therapy as the last resort, deterioration of diabetes with insulin, and viewing insulin therapy as a social stigma were significantly associated with the patients’ lower willingness to start this therapy.